...Impax Laboratories, Inc. engages in the development, manufacture, and marketing of specialty prescription pharmaceutical products utilizing its own formulation expertise and drug delivery technologies. As of March #, ####, the company had approximately ## generic products approved or pending approval, or under development, which consisted of ## abbreviated new drug applications (ANDAs) approved by the FDA, which include generic versions of brand name pharmaceuticals, such as Brethine, Florinef, Minocin, Claritin -D ## -hour, Claritin -D ## -hour, Wellbutrin SR, and Prilosec; ## applications pending at the FDA, including generic versions of OxyContin, Allegra D, and Tricor; and ## other products in various stages of development, which are for generic versions of brand name pharmaceuticals. The company sells its products to large pharmaceutical wholesalers, warehousing chain drug stores, mass merchandisers, and mail -order pharmacies through strategic alliances and the company...
|
